RIP assays (same experiments as Fig. 2l) confirmed the direct binding between MAGEA6 mRNA and the IGF2BP1 protein in A172 cells and the primary human glioma cells (Fig. 5a). This evidence concerns the gene IGF2BP1 and glioma.